Dual X-Ray Absorptiometry Whole Body Composition of Bone Tissue in Rheumatoid Arthritis-a Cross-Sectional Study

Claudiu Popescu, Violeta Bojinca, Daniela Opris, Ruxandra Ionescu
2015 Journal of Clinical Medicine CASE REPORTS CASE REPORTS 19 Maedica A Journal of Clinical Medicine   unpublished
Objectives: Previous studies of bone tissue in rheumatoid arthritis (RA) using dual X-ray absorpti-ometry (DXA) concentrated on regions of interest that were used to diagnose osteoporosis. This study aimed to compare the whole body bone tissue (wbBT) of RA patients with healthy subjects and to identify the RA variables which significantly predict wbBT. Methods: The study was cross-sectionally designed to include postmenopausal RA patients and age-matched healthy female controls. All 107 RA
more » ... nts and all 104 controls underwent clinical examination , laboratory tests and whole body DXA composition, which recorded total and regional bone indices. Non-parametric standard statistical test and regression models after data normalization were used to assess correlations, associations and differences. Results: Compared to controls, RA patients had significantly lower whole body and regional bone mass (14.9 kg compared to 15.5 kg; p = 0.031). Disease duration (r =-0.402 ; p < 0.001), C-reactive protein (r =-0.279; p = 0.015) and inflammation (2.5% wbBT compared to 2.9%; p = 0.043), radiographic damage (14.3 kg compared to 16.2 kg; p < 0.001), disease activity scores (r =-0.275 ; p = 0.018 for HAQ) are significantly correlated/associated with lower wbBT. Clinical structural damage is associated with lower wbBT and it can significantly predict them (R2 = 0.014; p = 0.001), while glucocorticoid treatment , even in low doses, was associated with lower wbBT percent (2.6% compared to 2.8%; p = 0.045). Treatment with biologics was associated with a lower rate of whole body osteoporosis (0% compared to 22.2%; p = 0.013). Conclusions: The main associated factors with the generalized bone loss in female RA patients are disease duration and disease activity. Clinical structural damage is the most powerful predictor of the whole body bone loss. These results suggest a general disturbance of skeletal bone metabolism in RA and could explain a greater risk of fragility fractures of non-central sites (e.g. ribs, tibia, ankles etc.) compared to post-menopause osteoporosis.